The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 10, 2017
Filed:
Oct. 08, 2004
Applicant:
Richard A. Bond, Houston, TX (US);
Inventor:
Richard A. Bond, Houston, TX (US);
Assignees:
EGB ADVISORS, LLC, Wilmington, DE (US);
INVION, INC., Melbourne, AU;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 31/138 (2006.01); A61K 31/137 (2006.01); A61K 31/192 (2006.01); A61K 31/403 (2006.01); A61K 31/46 (2006.01); A61K 31/47 (2006.01); A61K 31/522 (2006.01); A61K 31/56 (2006.01);
U.S. Cl.
CPC ...
A61K 31/138 (2013.01); A61K 31/137 (2013.01); A61K 31/192 (2013.01); A61K 31/403 (2013.01); A61K 31/46 (2013.01); A61K 31/47 (2013.01); A61K 31/522 (2013.01); A61K 31/56 (2013.01);
Abstract
The use of β-adrenergic inverse agonists provides a new and highly efficient way of treating a number of pulmonary airway diseases, including asthma, emphysema, and chronic obstructive pulmonary diseases. In general, such a method comprises administering a therapeutically effective amount of a β-adrenergic inverse agonist to the subject to treat the pulmonary airway disease. Particularly preferred inverse agonists include nadolol and carvedilol.